APA (7th ed.) Citation

García-Dorta, A., González-Dávila, E., Sánchez-Jareño, M., Cea-Calvo, L., Pombo-Suárez, M., Sánchez-Alonso, F., . . . Díaz-González, F. (2024). Early identification of golimumab-treated patients with higher likelihood of long-term retention. Frontiers in immunology, 15, 1359571. https://doi.org/10.3389/fimmu.2024.1359571

Chicago Style (17th ed.) Citation

García-Dorta, Alicia, Enrique González-Dávila, Marta Sánchez-Jareño, Luis Cea-Calvo, Manuel Pombo-Suárez, Fernando Sánchez-Alonso, Isabel Castrejón, and Federico Díaz-González. "Early Identification of Golimumab-treated Patients with Higher Likelihood of Long-term Retention." Frontiers in Immunology 15 (2024): 1359571. https://doi.org/10.3389/fimmu.2024.1359571.

MLA (9th ed.) Citation

García-Dorta, Alicia, et al. "Early Identification of Golimumab-treated Patients with Higher Likelihood of Long-term Retention." Frontiers in Immunology, vol. 15, 2024, p. 1359571, https://doi.org/10.3389/fimmu.2024.1359571.